Developer docs
API playgroundTry for free, no card

Search company profiles

Biobide

Full company profile

uuid000q3su

Namestring
Biobide
Legal namestring
BBD BIOPHENIX, S.L.
Websiteurl
biobide.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Biobide (legal entity BBD BIOPHENIX, S.L.) is a Contract Research Organization (CRO) headquartered at the Miramon Technology Park in San Sebastian, Spain, with a US sales subsidiary (BBD Biophenix USA LLC) in Boston, MA. Founded in 2005, the company provides preclinical toxicology and efficacy testing services using the zebrafish (Danio rerio) as an alternative vertebrate model, serving pharmaceutical, biotechnology, chemical, cosmetic, and nutraceutical clients, alongside patient advocacy organizations such as Duchenne Parent Project España and ApoyoDravet for rare disease research.

The company's core technology is a zebrafish-based preclinical platform comprising a facility housing more than 80,000 adult zebrafish across 35+ lines (some generated in-house), an Automated High Content Screening (HCS) platform operating in 96-well plate in vivo format, and a portfolio of more than 25 validated assays. These include general toxicity (Acutetox, Teratotox), specific organ toxicity (Cardiotox, Hepatotox, Neurotox, Ototox, Immunotox, Multitox, Kidney Toxicity, Muscle Toxicity, ALS Models, Sperm Quality), ecotoxicology under OECD guidelines (EASZY Estrogen Pathway, Daphnia Immobilization, Algae Growth Inhibition, Thyroid Disruption), efficacy (Angiogenesis Inhibition, Antioxidation, Regeneration, Melanin Quantification, Neurodegenerative/Rare Diseases), disease model generation via CRISPR, morpholinos, and transgenic techniques, and target validation services. Selected studies are conducted under Good Laboratory Practice (GLP) compliance for regulatory-grade aquatic ecotoxicology submissions.

Biobide generates revenue through project-based contracts with enterprise clients. Pricing is quote-based and project-specific, dependent on assay complexity, GLP requirements, and throughput, and is not publicly disclosed. Go-to-market is sales-led via business development representatives in Europe and a dedicated US team in Boston. The company has been a wholly-owned subsidiary of Biatgroup (formerly Bionaturis Group, MaB: BST) since 2014 and operates with 11-50 employees.

Short descriptiontext

Biobide is a Spain-based Contract Research Organization that provides preclinical toxicology, ecotoxicology, and efficacy testing services using zebrafish models for pharmaceutical, biotechnology, chemical, cosmetic, and nutraceutical clients, with a US sales subsidiary in Boston.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDonostia-san Sebastián, Spain
HQ citystring
Donostia-san Sebastián
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
zebrafish preclinical testing, contract research organization, ecotoxicology GLP studies, drug discovery assays, toxicology screening services
Industry2 codes
PRIMARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Preclinical Research Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Research Services
TypeProfessional Services
Description

Biobide operates as a Contract Research Organization (CRO) providing preclinical toxicity and efficacy testing services using zebrafish models. Services include general toxicity assays, specific toxicity assays, ecotoxicology assays, efficacy assays, disease model generation, and target validation services. Revenue is generated through project-based contracts with pharmaceutical, biotech, chemical, cosmetic, and nutraceutical companies.

biobide.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Biobide is a Contract Research Organization (CRO) that sells zebrafish-based preclinical testing services to pharmaceutical, biotech, chemical, cosmetic, and nutraceutical companies. Offerings include general and specific toxicity assays, aquatic ecotoxicology studies, efficacy assays, custom disease model generation, and target validation services, executed under Good Laboratory Practice (GLP) standards via an automated High Content Screening platform.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Time and cost reduction in drug development through efficient zebrafish screening
+1 more record
Product overview1 text field

Biobide is a Contract Research Organization (CRO) specializing in zebrafish-based preclinical testing services. The company offers a comprehensive portfolio of validated toxicity and efficacy assays, disease model generation, and target validation services organized into five main categories: General-Toxicity-Assays (Acutetox, Teratotox), Specific-Toxicity-Assays (Cardiotox, Hepatotox, Neurotox, Ototox, Immunotox, Multitox, Kidney Toxicity, Muscle Toxicity, ALS Models, Sperm Quality), Ecotox-Assays (FET Test, Daphnia Immobilization, Algae Growth Inhibition, EASZY Estrogen Pathway, Thyroid Disruption), Efficacy-Assays (Angiogenesis Inhibition, Antioxidation, Regeneration, Melanin Quantification, Neurodegenerative/Rare Diseases), and Disease-Model-Generation/Target-Validation services. All services can be conducted under GLP compliance for regulatory submissions. The company also provides an Automated High Content Screening (HCS) platform for high-throughput compound screening using fluorescent zebrafish lines.

Product and service26 records
1Acutetox Assay (General Toxicity)
CategoryGeneral Toxicity Assays
Description

Rapid preliminary acute toxicity testing service using zebrafish embryos to provide early safety assessment of compounds for pharmaceutical, chemical, cosmetic, and nutraceutical clients.

2Teratotox Assay
CategoryGeneral Toxicity Assays
Description

Teratogenicity testing service that evaluates developmental toxicity and malformations across multiple morphological endpoints in zebrafish embryos.

3Cardiotox Assay
CategorySpecific Toxicity Assays
Description

Cardiovascular toxicity screening service leveraging fluorescent zebrafish lines for real-time cardiac assessment of drug candidates and chemicals.

4Hepatotox Assay
CategorySpecific Toxicity Assays
Description

Hepatotoxicity assessment service using zebrafish liver models to evaluate drug-induced liver injury for pharmaceutical and chemical safety programs.

5Neurotox Assay
CategorySpecific Toxicity Assays
Description

Neurotoxicity screening service evaluating compound effects on nervous system development and function in zebrafish embryos.

6Ototox Assay
CategorySpecific Toxicity Assays
Description

Ototoxicity testing service for assessing drug-induced hearing and balance system damage using zebrafish models.

7Immunotox Assay
CategorySpecific Toxicity Assays
Description

Immunotoxicity assessment service evaluating compound effects on immune system development and function in zebrafish.

8Multitox Assay
CategorySpecific Toxicity Assays
Description

Comprehensive multi-organ toxicity screening service assessing compound effects across multiple tissue types simultaneously in zebrafish embryos.

9Kidney Toxicity Assay
CategorySpecific Toxicity Assays
Description

Nephrotoxicity assessment service using zebrafish to evaluate compound effects on kidney development and function.

10Muscle Toxicity Assay
CategorySpecific Toxicity Assays
Description

Assessment of myotoxicity and muscle development effects using zebrafish disease models.

11Zebrafish Models for Amyotrophic Lateral Sclerosis (ALS)
CategorySpecific Toxicity Assays / Disease Model Generation
Description

Disease model generation service for amyotrophic lateral sclerosis using zebrafish to study neurodegenerative mechanisms and evaluate candidate therapeutics.

12Sperm Quality Assessment
CategorySpecific Toxicity Assays
Description

Evaluation of reproductive toxicity through analysis of sperm quality parameters in zebrafish models.

13Zebrafish Sperm Cryopreservation and In Vitro Fertilization
CategorySpecific Toxicity Assays
Description

Specialized service for cryopreservation of zebrafish sperm and in vitro fertilization techniques to support client research and breeding programs.

14Acutetox Assay - Ecotox
CategoryEcotoxicology Assays
Description

Fish embryo acute toxicity test following OECD 236 Guideline for environmental risk assessment of chemicals, targeting chemical and agrochemical registrants.

15Daphnia Immobilization Test
CategoryEcotoxicology Assays
Description

Acute immobilization test with Daphnia magna for aquatic toxicity assessment per OECD guidelines, supporting chemical registration studies.

16Microplate Alga Growth Inhibition Test
CategoryEcotoxicology Assays
Description

Algal growth inhibition assay for evaluating aquatic toxicity of chemical compounds, supporting ecotoxicology regulatory submissions.

17EASZY Assay (Estrogen Pathway)
CategoryEcotoxicology Assays / Specific Toxicity Assays
Description

Estrogen pathway assay for ecotoxicological assessment, evaluating endocrine-disrupting effects of compounds using zebrafish embryos.

18Thyroid Disruption Assay
CategoryEcotoxicology Assays
Description

Endocrine disruption assessment targeting the thyroid pathway using zebrafish embryos for chemical and pharmaceutical safety programs.

19Antioxidation Assay
CategoryEfficacy Assays
Description

Antioxidant capacity evaluation service for cosmetics, nutraceuticals, and pharmaceutical compounds using zebrafish embryos.

20Regeneration Assay
CategoryEfficacy Assays
Description

Tissue regeneration assessment using zebrafish's natural regenerative capabilities to evaluate therapeutic potential for pharmaceutical clients.

21Melanin Quantification Assay
CategoryEfficacy Assays
Description

Pigmentation analysis service for evaluating melanogenesis and skin-lightening compound efficacy, used by cosmetic clients.

22Neurodegenerative and Rare Diseases Models
CategoryEfficacy Assays / Disease Model Generation
Description

Zebrafish-based disease models for studying Alzheimer's, Parkinson's, epilepsy, Dravet syndrome, and other rare diseases for translational research.

23Cancer: Angiogenesis Inhibition Assay
CategoryEfficacy Assays
Description

Anti-angiogenic efficacy testing service using zebrafish tumor models to evaluate anticancer compounds.

24Disease Model Generation
CategoryDisease Model Generation
Description

Custom zebrafish disease model generation service using CRISPR, morpholinos, and transgenic techniques tailored to specific client research needs.

25Target Validation Services
CategoryTarget Validation
Description

Gene target identification and validation service using zebrafish models to support early drug discovery and lead selection for pharmaceutical and biotech clients.

26GLP Aquatic Ecotoxicology Studies
CategoryRegulatory Compliance Services
Description

Good Laboratory Practice (GLP) compliant aquatic ecotoxicology studies for regulatory submission following international guidelines, offered to chemical, agrochemical, and pharmaceutical registrants.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
Strategic tierMinorTypeOthers
Description

Spanish biotechnology association membership providing networking, industry advocacy, and visibility within the Spanish biotech ecosystem.

2BasqueBio
Strategic tierMinorTypeOthers
Description

Basque health cluster association connecting biotechnology companies in the Basque region for collaborative opportunities.

biobide.com
3Biobasque
Strategic tierMinorTypeOthers
Description

Basque biotechnology organization supporting biotech development and collaboration in the region.

biobide.com
4DIA
Strategic tierMinorTypeOthers
Description

Drug Information Association - global forum for regulated healthcare product discussions and regulatory science.

biobide.com
5ETS (European Teratology Society)
Strategic tierMinorTypeOthers
Description

European scientific society focused on developmental and reproductive toxicology.

biobide.com
6Eufish Biomed
Strategic tierMinorTypeStrategic or Co-development Partner
Description

European consortium for fish biomedicine research, providing collaborative opportunities in aquatic model organism research.

biobide.com
7HOT (Human Toxicology - OECD)
Strategic tierMinorTypeOthers
Description

Human toxicology special interest group under the Society of Toxicology focusing on alternative testing methods.

biobide.com
Strategic tierMinorTypeOthers
Description

Nanomedicine Spain association for hearing research and ototoxicity expertise.

9SPS (Safety Pharmacology Society)
Strategic tierMinorTypeOthers
Description

Global society dedicated to safety pharmacology, supporting regulatory science and best practices.

biobide.com
10SETAC
Strategic tierMinorTypeOthers
Description

Society of Environmental Toxicology and Chemistry - global organization for ecotoxicology and environmental science.

biobide.com
11SOT (Society of Toxicology)
Strategic tierMinorTypeOthers
Description

Professional society for toxicology researchers and practitioners, providing conference participation and industry networking.

biobide.com
Strategic tierMinorTypeOthers
Description

University of Oregon-based zebrafish model organism database and community resource.

Strategic tierMinorTypeOthers
Description

International organization dedicated to excellence in zebrafish husbandry and facility management standards.

14Hazitek Projects
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Basque government-funded R&D support programs including Hazitek 2025, Daniobit 2023, and other innovation projects supporting zebrafish research development.

biobide.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

US subsidiary of Biobide operating as a sales and business development office in Boston, MA, responsible for North American market engagement and client relationships.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

International testing services group with significant life sciences and preclinical testing capabilities. Comparable broad incumbent providing toxicology and ecotoxicology testing services to overlapping enterprise clients.

TypeBroad incumbent
Description

Global large-cap CRO with broad preclinical and drug discovery services, including zebrafish-based screening capabilities. Comparable as a broad incumbent in preclinical CRO services targeting the same pharma/biotech customers.

TypeEmerging player
Description

US-based preclinical CRO focused on nonclinical safety assessment, toxicology, and research models. Comparable emerging-to-mid player competing for the same preclinical toxicology spend as Biobide.

TypeEmerging player
Description

Hearing research CRO using zebrafish ototoxicity models (a partnership referenced in Biobide's alliance list). Comparable emerging player with overlapping zebrafish-based ototoxicity/preclinical service offerings.

TypeBroad incumbent
Description

Global CRO/CDMO offering preclinical, toxicology, and integrated drug development services. Comparable broad incumbent competing for preclinical toxicology and discovery contracts with the same pharma/biotech clients.

TypeDirect peer
Description

Barcelona-based zebrafish CRO providing preclinical toxicity and efficacy services to pharma and biotech. Direct peer — same zebrafish model, same preclinical CRO offering, with overlapping enterprise pharma customer base.

TypeBroad incumbent
Description

Large global CRO with extensive preclinical safety/toxicology services and a broad portfolio. Comparable as a broad incumbent competing for the same preclinical safety and toxicology budgets as Biobide.

TypeEmerging player
Description

Mid-sized CRO offering preclinical and analytical services for biologics developers. Comparable emerging player in the broader preclinical CRO space serving pharma/biotech customers with overlapping needs.

9Labcorp Early Development
TypeBroad incumbent
Description

Global CRO offering preclinical, nonclinical safety assessment, and analytical services through its Early Development segment. Comparable broad incumbent in the same preclinical toxicology category as Biobide.

10Phylonix Pharmaceuticals
TypeDirect peer
Description

US-based zebrafish CRO offering preclinical drug discovery, toxicity, and efficacy testing services using zebrafish models. Direct peer — comparable specialty CRO business model focused exclusively on the zebrafish platform.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biobide

Preclinical Research Servicesbiobide.com

Biobide is a Spain-based Contract Research Organization that provides preclinical toxicology, ecotoxicology, and efficacy testing services using zebrafish models for pharmaceutical, biotechnology, chemical, cosmetic, and nutraceutical clients, with a US sales subsidiary in Boston.

What Biobide does

Biobide (legal entity BBD BIOPHENIX, S.L.) is a Contract Research Organization (CRO) headquartered at the Miramon Technology Park in San Sebastian, Spain, with a US sales subsidiary (BBD Biophenix USA LLC) in Boston, MA. Founded in 2005, the company provides preclinical toxicology and efficacy testing services using the zebrafish (Danio rerio) as an alternative vertebrate model, serving pharmaceutical, biotechnology, chemical, cosmetic, and nutraceutical clients, alongside patient advocacy organizations such as Duchenne Parent Project España and ApoyoDravet for rare disease research.

The company's core technology is a zebrafish-based preclinical platform comprising a facility housing more than 80,000 adult zebrafish across 35+ lines (some generated in-house), an Automated High Content Screening (HCS) platform operating in 96-well plate in vivo format, and a portfolio of more than 25 validated assays. These include general toxicity (Acutetox, Teratotox), specific organ toxicity (Cardiotox, Hepatotox, Neurotox, Ototox, Immunotox, Multitox, Kidney Toxicity, Muscle Toxicity, ALS Models, Sperm Quality), ecotoxicology under OECD guidelines (EASZY Estrogen Pathway, Daphnia Immobilization, Algae Growth Inhibition, Thyroid Disruption), efficacy (Angiogenesis Inhibition, Antioxidation, Regeneration, Melanin Quantification, Neurodegenerative/Rare Diseases), disease model generation via CRISPR, morpholinos, and transgenic techniques, and target validation services. Selected studies are conducted under Good Laboratory Practice (GLP) compliance for regulatory-grade aquatic ecotoxicology submissions.

Biobide generates revenue through project-based contracts with enterprise clients. Pricing is quote-based and project-specific, dependent on assay complexity, GLP requirements, and throughput, and is not publicly disclosed. Go-to-market is sales-led via business development representatives in Europe and a dedicated US team in Boston. The company has been a wholly-owned subsidiary of Biatgroup (formerly Bionaturis Group, MaB: BST) since 2014 and operates with 11-50 employees.

Biobide firmographics

Firmographics
Name
Biobide
Legal name
BBD BIOPHENIX, S.L.
Website
https://biobide.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
11–50 employees
Short description
Biobide is a Spain-based Contract Research Organization that provides preclinical toxicology, ecotoxicology, and efficacy testing services using zebrafish models for pharmaceutical, biotechnology, chemical, cosmetic, and nutraceutical clients, with a US sales subsidiary in Boston.
Ownership category
akta.pro rank

Biobide industry classification

Industry
Product category
Preclinical Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)

Keywords

  • Zebrafish preclinical testing
  • Contract research organization
  • Ecotoxicology GLP studies
  • Drug discovery assays
  • Toxicology screening services

Where Biobide is headquartered

Location

Headquarters

HQ city
Donostia-san Sebastián
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

Biobide business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Contract Research Services: Biobide operates as a Contract Research Organization (CRO) providing preclinical toxicity and efficacy testing services using zebrafish models. Services include general toxicity assays, specific toxicity assays, ecotoxicology assays, efficacy assays, disease model generation, and target validation services. Revenue is generated through project-based contracts with pharmaceutical, biotech, chemical, cosmetic, and nutraceutical companies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Biobide product offering

Product offering

Core offering

Biobide is a Contract Research Organization (CRO) that sells zebrafish-based preclinical testing services to pharmaceutical, biotech, chemical, cosmetic, and nutraceutical companies. Offerings include general and specific toxicity assays, aquatic ecotoxicology studies, efficacy assays, custom disease model generation, and target validation services, executed under Good Laboratory Practice (GLP) standards via an automated High Content Screening platform.

Product overview

Biobide is a Contract Research Organization (CRO) specializing in zebrafish-based preclinical testing services. The company offers a comprehensive portfolio of validated toxicity and efficacy assays, disease model generation, and target validation services organized into five main categories: General-Toxicity-Assays (Acutetox, Teratotox), Specific-Toxicity-Assays (Cardiotox, Hepatotox, Neurotox, Ototox, Immunotox, Multitox, Kidney Toxicity, Muscle Toxicity, ALS Models, Sperm Quality), Ecotox-Assays (FET Test, Daphnia Immobilization, Algae Growth Inhibition, EASZY Estrogen Pathway, Thyroid Disruption), Efficacy-Assays (Angiogenesis Inhibition, Antioxidation, Regeneration, Melanin Quantification, Neurodegenerative/Rare Diseases), and Disease-Model-Generation/Target-Validation services. All services can be conducted under GLP compliance for regulatory submissions. The company also provides an Automated High Content Screening (HCS) platform for high-throughput compound screening using fluorescent zebrafish lines.

Differentiator

Problem solved

Functional benefit

Products and services

  • Acutetox Assay (General Toxicity) Rapid preliminary acute toxicity testing service using zebrafish embryos to provide early safety assessment of compounds for pharmaceutical, chemical, cosmetic, and nutraceutical clients.
  • Teratotox Assay Teratogenicity testing service that evaluates developmental toxicity and malformations across multiple morphological endpoints in zebrafish embryos.
  • Cardiotox Assay Cardiovascular toxicity screening service leveraging fluorescent zebrafish lines for real-time cardiac assessment of drug candidates and chemicals.
  • Hepatotox Assay Hepatotoxicity assessment service using zebrafish liver models to evaluate drug-induced liver injury for pharmaceutical and chemical safety programs.
  • Neurotox Assay Neurotoxicity screening service evaluating compound effects on nervous system development and function in zebrafish embryos.
  • Ototox Assay Ototoxicity testing service for assessing drug-induced hearing and balance system damage using zebrafish models.
  • Immunotox Assay Immunotoxicity assessment service evaluating compound effects on immune system development and function in zebrafish.
  • Multitox Assay Comprehensive multi-organ toxicity screening service assessing compound effects across multiple tissue types simultaneously in zebrafish embryos.
  • Kidney Toxicity Assay Nephrotoxicity assessment service using zebrafish to evaluate compound effects on kidney development and function.
  • Muscle Toxicity Assay Assessment of myotoxicity and muscle development effects using zebrafish disease models.
  • Zebrafish Models for Amyotrophic Lateral Sclerosis (ALS) Disease model generation service for amyotrophic lateral sclerosis using zebrafish to study neurodegenerative mechanisms and evaluate candidate therapeutics.
  • Sperm Quality Assessment Evaluation of reproductive toxicity through analysis of sperm quality parameters in zebrafish models.
  • Zebrafish Sperm Cryopreservation and In Vitro Fertilization Specialized service for cryopreservation of zebrafish sperm and in vitro fertilization techniques to support client research and breeding programs.
  • Acutetox Assay - Ecotox Fish embryo acute toxicity test following OECD 236 Guideline for environmental risk assessment of chemicals, targeting chemical and agrochemical registrants.
  • Daphnia Immobilization Test Acute immobilization test with Daphnia magna for aquatic toxicity assessment per OECD guidelines, supporting chemical registration studies.
  • Microplate Alga Growth Inhibition Test Algal growth inhibition assay for evaluating aquatic toxicity of chemical compounds, supporting ecotoxicology regulatory submissions.
  • EASZY Assay (Estrogen Pathway) Estrogen pathway assay for ecotoxicological assessment, evaluating endocrine-disrupting effects of compounds using zebrafish embryos.
  • Thyroid Disruption Assay Endocrine disruption assessment targeting the thyroid pathway using zebrafish embryos for chemical and pharmaceutical safety programs.
  • Antioxidation Assay Antioxidant capacity evaluation service for cosmetics, nutraceuticals, and pharmaceutical compounds using zebrafish embryos.
  • Regeneration Assay Tissue regeneration assessment using zebrafish's natural regenerative capabilities to evaluate therapeutic potential for pharmaceutical clients.
  • Melanin Quantification Assay Pigmentation analysis service for evaluating melanogenesis and skin-lightening compound efficacy, used by cosmetic clients.
  • Neurodegenerative and Rare Diseases Models Zebrafish-based disease models for studying Alzheimer's, Parkinson's, epilepsy, Dravet syndrome, and other rare diseases for translational research.
  • Cancer: Angiogenesis Inhibition Assay Anti-angiogenic efficacy testing service using zebrafish tumor models to evaluate anticancer compounds.
  • Disease Model Generation Custom zebrafish disease model generation service using CRISPR, morpholinos, and transgenic techniques tailored to specific client research needs.
  • Target Validation Services Gene target identification and validation service using zebrafish models to support early drug discovery and lead selection for pharmaceutical and biotech clients.
  • GLP Aquatic Ecotoxicology Studies Good Laboratory Practice (GLP) compliant aquatic ecotoxicology studies for regulatory submission following international guidelines, offered to chemical, agrochemical, and pharmaceutical registrants.

Quantifiable outcome

  • Time and cost reduction in drug development through efficient zebrafish screening
  • +1 more outcomes

Companies that use Biobide

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles4 records

Biobide technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Biobide partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered minor and core.

  • ASEBIOminorOthersSpanish biotechnology association membership providing networking, industry advocacy, and visibility within the Spanish biotech ecosystem.
  • BasqueBiominorOthersBasque health cluster association connecting biotechnology companies in the Basque region for collaborative opportunities.
  • BiobasqueminorOthersBasque biotechnology organization supporting biotech development and collaboration in the region.
  • DIAminorOthersDrug Information Association - global forum for regulated healthcare product discussions and regulatory science.
  • ETS (European Teratology Society)minorOthersEuropean scientific society focused on developmental and reproductive toxicology.
  • Eufish BiomedminorStrategic or Co-development PartnerEuropean consortium for fish biomedicine research, providing collaborative opportunities in aquatic model organism research.
  • HOT (Human Toxicology - OECD)minorOthersHuman toxicology special interest group under the Society of Toxicology focusing on alternative testing methods.
  • CILcareminorOthersNanomedicine Spain association for hearing research and ototoxicity expertise.
  • SPS (Safety Pharmacology Society)minorOthersGlobal society dedicated to safety pharmacology, supporting regulatory science and best practices.
  • SETACminorOthersSociety of Environmental Toxicology and Chemistry - global organization for ecotoxicology and environmental science.
  • SOT (Society of Toxicology)minorOthersProfessional society for toxicology researchers and practitioners, providing conference participation and industry networking.
  • ZFIN (Zebrafish Information Network)minorOthersUniversity of Oregon-based zebrafish model organism database and community resource.
  • ZHA (Zebrafish Husbandry Association)minorOthersInternational organization dedicated to excellence in zebrafish husbandry and facility management standards.
  • Hazitek ProjectsminorStrategic or Co-development PartnerBasque government-funded R&D support programs including Hazitek 2025, Daniobit 2023, and other innovation projects supporting zebrafish research development.
  • BBD Biophenix USA LLCcoreChannel Partner/ Reseller/ DistributorUS subsidiary of Biobide operating as a sales and business development office in Boston, MA, responsible for North American market engagement and client relationships.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Biobide competitors and assessment

Company assessment

Broad incumbents

  • Eurofins Scientific: International testing services group with significant life sciences and preclinical testing capabilities. Comparable broad incumbent providing toxicology and ecotoxicology testing services to overlapping enterprise clients.
  • Evotec: Global large-cap CRO with broad preclinical and drug discovery services, including zebrafish-based screening capabilities. Comparable as a broad incumbent in preclinical CRO services targeting the same pharma/biotech customers.
  • WuXi AppTec: Global CRO/CDMO offering preclinical, toxicology, and integrated drug development services. Comparable broad incumbent competing for preclinical toxicology and discovery contracts with the same pharma/biotech clients.
  • Charles River Laboratories: Large global CRO with extensive preclinical safety/toxicology services and a broad portfolio. Comparable as a broad incumbent competing for the same preclinical safety and toxicology budgets as Biobide.
  • Labcorp Early Development: Global CRO offering preclinical, nonclinical safety assessment, and analytical services through its Early Development segment. Comparable broad incumbent in the same preclinical toxicology category as Biobide.

Emerging players

  • Inotiv: US-based preclinical CRO focused on nonclinical safety assessment, toxicology, and research models. Comparable emerging-to-mid player competing for the same preclinical toxicology spend as Biobide.
  • CILcare: Hearing research CRO using zebrafish ototoxicity models (a partnership referenced in Biobide's alliance list). Comparable emerging player with overlapping zebrafish-based ototoxicity/preclinical service offerings.
  • Bionova Scientific: Mid-sized CRO offering preclinical and analytical services for biologics developers. Comparable emerging player in the broader preclinical CRO space serving pharma/biotech customers with overlapping needs.

Direct peers

  • ZeClinics: Barcelona-based zebrafish CRO providing preclinical toxicity and efficacy services to pharma and biotech. Direct peer — same zebrafish model, same preclinical CRO offering, with overlapping enterprise pharma customer base.
  • Phylonix Pharmaceuticals: US-based zebrafish CRO offering preclinical drug discovery, toxicity, and efficacy testing services using zebrafish models. Direct peer — comparable specialty CRO business model focused exclusively on the zebrafish platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Biobide social profiles

Digital presence

Biobide financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biobide leadership team

Management profile

Number of profiles

Profiles9 records

Biobide subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Biobide funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biobide M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biobide

What does Biobide do?

Biobide is a Contract Research Organization (CRO) that sells zebrafish-based preclinical testing services to pharmaceutical, biotech, chemical, cosmetic, and nutraceutical companies. Offerings include general and specific toxicity assays, aquatic ecotoxicology studies, efficacy assays, custom disease model generation, and target validation services, executed under Good Laboratory Practice (GLP) standards via an automated High Content Screening platform.

Is Biobide a public or private company?

Biobide is a private company. It is classified as corporate owned and is currently operating.

When was Biobide founded?

Biobide was founded in 2005. It employs 11 to 50 people.

Where is Biobide based?

Biobide is headquartered in Donostia-san Sebastián, Spain, in the Europe region.

How does Biobide make money?

One revenue line is on record: contract Research Services.

Who are Biobide's main competitors?

Broad incumbents on record are Eurofins Scientific, Evotec, WuXi AppTec, Charles River Laboratories and Labcorp Early Development. Emerging players are Inotiv, CILcare and Bionova Scientific. Direct peers are ZeClinics and Phylonix Pharmaceuticals.

Does Biobide have an API?

No public API is recorded for Biobide.

What industry is Biobide in?

Biobide's product category is Preclinical Research Services. Its primary akta.pro industry code is HLAGAAAC, Toxicology & Safety Assessment CROs (GLP), with a secondary code of HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals